New diagnostic and therapeutic tools
against multidrug resistant tumours






PANDORA (CIG17104) - Pan-European Educational Platform
on Multidrug Resistant Tumours and Personalised Cancer Treatment
We continue exploring STRATAGEM's innovation potential for another year

We aim to improve both
the diagnosis and therapy
of multidrug resistant (MDR)
solid tumours.

Welcome!

STRATAGEM contributes to Covid-19 research

Fighting together
against multidrug
resistant tumours

Special
issues
edited by
our scientists

Working
Group 1

Identification of new biomarkers and therapeutic targets for MDR tumours

Working
Group 2

Synthesis and nanodelivery strategies for new therapeutic tools against MDR tumours

Working
Group 3

Efficacy validation of new therapeutic tools against pre-clinical models of MDR tumours

Working
Group 4

Pharmacokinetics and ADMET of the new therapeutic tools; safety of the targets

Forum

Events / News